Author: Eldon Marr

SAN FRANCISCO – May 12, 2022 – Medicines360, the mission-driven nonprofit women’s health pharmaceutical organization, has appointed Elizabeth Garner MD, MPH, as a member of its Board of Directors, effective immediately. With over a decade of pharmaceutical development experience, Dr. Garner brings expansive knowledge in regulatory and clinical affairs, and a deep commitment to increasing […]

  • Posted in Press Releases
  • Comments Off on Medicines360 Appoints Elizabeth Garner, M.D., M.P.H. to Board of Directors 

As the leading nonprofit pharmaceutical company addressing women’s most pressing reproductive health needs, Medicines360 welcomes the new Department of Health and Human Services (HHS) rule restoring Title X health care providers’ right to give their patients comprehensive, medically accurate health information. “At Medicines360, we know all women deserve access to the full range of contraceptive options and […]

  • Posted in Blog
  • Comments Off on Medicines360 Statement on New Title X Rule

Contraceptive choice, access, and affordability are core determinants of an individuals’ economic and personal health. Access to contraceptives has improved women’s rates of enrollment and graduation from higher education, contributed to significant increases in women’s participation in the workforce, and is connected to increased wages.[i] Federally Qualified Health Centers (FQHCs) are community-based providers that exist to meet patients where […]

  • Posted in Blog
  • Comments Off on Collaborative Research to Document the Impact of Reimbursement Changes on Access to Long-Acting, Reversible Contraception

At Medicines360, our culture is built on a shared passion for advancing women’s health, driven by a team of experts who know the science, and trailblazers who shape new systems and construct solutions for the challenges women face every day. When Stacey Manley previously worked at Medicines360, it marked his first foray into social impact […]

  • Posted in Blog
  • Comments Off on Three Things to Know About Our New Vice President of Communications & Marketing

Product Expands Access to High-Quality Contraception for Women in Africa SAN FRANCISCO and LONDON and NAIROBI– August 2, 2021 – Medicines360, MSI Reproductive Choices (MSI) and Marie Stopes Kenya (MSK) today announced the launch of AVIBELA (levonorgestrel-releasing intrauterine system) 52 mg in Kenya. This is the third launch of Medicines360’s hormonal intrauterine device (IUD) in […]

  • Posted in Press Releases
  • Comments Off on Medicines360, MSI Reproductive Choices and MSK Announce Launch of Avibela® Hormonal Intrauterine Device in Kenya

Dr. Raine-Bennett brings passionate expertise in improving health outcomes for women SAN FRANCISCO – July 6, 2021 – Medicines360, a global nonprofit women’s health pharmaceutical organization, has appointed Tina Raine-Bennett, MD, MPH, FACOG, Chief Executive Officer (CEO), effective immediately, following a broad national search. With over 30 years of experience, Dr. Raine-Bennett has an extensive […]

  • Posted in Press Releases
  • Comments Off on Medicines360 Appoints Tina Raine-Bennett, MD, MPH, FACOG, as Chief Executive Officer